India to Philippines: Gefitinib Export Trade Route
India has recorded 21 verified shipments of Gefitinib exported to Philippines, representing a combined trade value of $374.1K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $17.8K USD. The leading Indian exporter is NAPROD LIFE SCIENCES PRIVATE LIMITED , which accounts for 46% of total export value with 4 shipments worth $170.6K USD. On the buying side, Natco LifeSciences Phillipines Inc is the largest importer in Philippines with $170.6K USD in purchases. The top 3 suppliers — NAPROD LIFE SCIENCES PRIVATE LIMITED , NAPROD LIFE SCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD. — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Gefitinib corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $374.1K USD. The route is dominated by NAPROD LIFE SCIENCES PRIVATE LIMITED , which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's gefitinib manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $17.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with gefitinib's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 32.1%, placing it at rank #12 among India's top gefitinib export destinations globally.
On the import side, key buyers of Indian gefitinib in Philippines include Natco LifeSciences Phillipines Inc , NATCO LIFESCIENCES PHILIPPINES, Ve Pharma Inc. and 6 others. Natco LifeSciences Phillipines Inc is the single largest importer with 4 shipments valued at $170.6K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#12
- Annual growth+32.1%
- Demand growth+28.6%
- Regulatory ease75/100
Top 10 Indian Gefitinib Exporters to Philippines
Showing top 10 of 9 Indian suppliers exporting Gefitinib to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $42.6K per shipment | 4 | $170.6K | 45.6% |
| 2 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $71.4K per shipment | 2 | $142.8K | 38.2% |
| 3 | VEXXA LIFESCIENCES PVT. LTD. Avg $5.7K per shipment | 4 | $22.8K | 6.1% |
| 4 | VEXXA LIFESCIENCES PVT. LTD. Avg $5.7K per shipment | 4 | $22.8K | 6.1% |
| 5 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $10.7K per shipment | 1 | $10.7K | 2.9% |
| 6 | JODAS EXPOIM PRIVATE LIMITED Avg $3.6K per shipment | 1 | $3.6K | 1.0% |
| 7 | IKRIS PHARMA NETWORK PRIVATE LIMITED Avg $356 per shipment | 1 | $356 | 0.1% |
| 8 | MAGICINE PHARMA Avg $105 per shipment | 3 | $315 | 0.1% |
| 9 | HEET HEALTHCARE PRIVATE LIMITED Avg $198 per shipment | 1 | $198 | 0.1% |
This table shows the top 10 of 9 Indian companies exporting gefitinib to Philippines, ranked by total trade value. The listed exporters are: NAPROD LIFE SCIENCES PRIVATE LIMITED , NAPROD LIFE SCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED, IKRIS PHARMA NETWORK PRIVATE LIMITED , MAGICINE PHARMA, HEET HEALTHCARE PRIVATE LIMITED. NAPROD LIFE SCIENCES PRIVATE LIMITED is the dominant supplier with 4 shipments worth $170.6K USD, giving it a 46% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Gefitinib Importers in Philippines
Showing top 10 of 9 known buyers in Philippines receiving Gefitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gefitinib in Philippines include Natco LifeSciences Phillipines Inc , NATCO LIFESCIENCES PHILIPPINES, Ve Pharma Inc. , VE PHARMA INC, Ve Pharma Inc., among 9 total buyers. The largest importer is Natco LifeSciences Phillipines Inc , accounting for $170.6K USD across 4 shipments — representing 46% of all gefitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Natco LifeSciences Phillipines Inc | 4 | $170.6K | 45.6% |
| 2 | NATCO LIFESCIENCES PHILIPPINES | 2 | $142.8K | 38.2% |
| 3 | Ve Pharma Inc. | 4 | $22.8K | 6.1% |
| 4 | VE PHARMA INC | 3 | $22.1K | 5.9% |
| 5 | Ve Pharma Inc. | 2 | $11.4K | 3.0% |
| 6 | BLISS PHARMA DISTRIBUTION AND | 1 | $3.6K | 1.0% |
| 7 | BINH LAURENA C/O CAROLYN LAURENA | 1 | $356 | 0.1% |
| 8 | KRISJE LAGRADA | 3 | $315 | 0.1% |
| 9 | TO THE ORDER | 1 | $198 | 0.1% |
Top 10 Gefitinib Formulations Imported by Philippines
Showing top 10 of 13 product formulations shipped on the India to Philippines Gefitinib route, ranked by trade value
Philippines imports a wide range of gefitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Gefonib 250mg Gefitinib Tablets 250mg — accounts for $170.6K USD across 4 shipments. There are 13 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Gefonib 250mg Gefitinib Tablets 250mg | 4 | $170.6K | 45.6% |
| 2 | GEFONIB 250MG GEFITINIB TABLETS 250MG 1 | 1 | $76.6K | 20.5% |
| 3 | GEFONIB 250MG GEFITINIB TABLETS 250MG B.NO. NT4032A MFG.DT.05/2024 EXP.DT. 04/2026 | 1 | $66.1K | 17.7% |
| 4 | Gafvex 250 (GEFITINIB TABLETS 250MG) | 4 | $22.8K | 6.1% |
| 5 | Gafvex 250 Tab (GEFITINIB TABLETS 250MG)BATCH NO-GETL24A11-B MFG DT-DEC-2024 EXP DT-NOV-2026 | 2 | $11.4K | 3.1% |
| 6 | Gafvex 250 (GEFITINIB TABLETS 250MG) BAT | 2 | $11.4K | 3.0% |
| 7 | GAFVEX 250 GEFITINIB TABLETS 250MG B.NO.GETJ23A08-A MANUFACTURING DT OCT-2023 EXP DTSEP-2025 | 1 | $10.7K | 2.9% |
| 8 | GEFITINIB TABLETS 250MG (3X10 TABLETS ALU-PVC BLISTER PACKS) [QUALITINIB] (QTY:100 PACKS X 30 S = 3000 NOS)NOS | 1 | $3.6K | 1.0% |
| 9 | GEFTINAT TABLET EACH TABLET OF GEFITINIB | 1 | $356 | 0.1% |
| 10 | Geftinat Gefitinib (250mg) Batch : 70272 | 1 | $198 | 0.1% |
Showing top 10 of 13 Gefitinib formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 12 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's gefitinib exports to Philippines are driven primarily by a handful of large-scale manufacturers. NAPROD LIFE SCIENCES PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NAPROD LIFE SCIENCES PRIVATE LIMITED , NAPROD LIFE SCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD. — together account for 90% of total trade value on this route. The average shipment value of $17.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as gefonib 250mg gefitinib tablets 250mg 1 and gefonib 250mg gefitinib tablets 250mg b.no. nt4032a mfg.dt.05/2024 exp.dt. 04/2026, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Natco LifeSciences Phillipines Inc is the largest importer with 4 shipments worth $170.6K USD — representing 46% of all gefitinib imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $374.1K
- Avg. Shipment
- $17.8K
- Suppliers
- 9
- Buyers
- 9
- Transit (Sea)
- ~16 days
- Annual Growth
- +32.1%
Other Gefitinib Routes
Unlock the Full India to Philippines Gefitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 21 shipments on this route.
Frequently Asked Questions — India to Philippines Gefitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gefitinib to Philippines?
The leading Indian exporters of Gefitinib to Philippines are NAPROD LIFE SCIENCES PRIVATE LIMITED , NAPROD LIFE SCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD.. NAPROD LIFE SCIENCES PRIVATE LIMITED holds the largest market share at approximately 46% of total trade value on this route.
Q What is the total value of Gefitinib exports from India to Philippines?
India exports Gefitinib to Philippines worth approximately $374.1K USD across 21 recorded shipments. The average value per shipment is $17.8K USD.
Q Which ports does India use to ship Gefitinib to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 12 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Philippines for Gefitinib?
The average transit time for Gefitinib shipments from India to Philippines is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Philippines Gefitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.1% with demand growth tracking at 28.6%. The route is ranked #12 among India's top Gefitinib export destinations globally.
Q How many suppliers are active on the India to Philippines Gefitinib route?
There are currently 9 active Indian suppliers exporting Gefitinib to Philippines. The market is moderately concentrated with NAPROD LIFE SCIENCES PRIVATE LIMITED accounting for 46% of total shipment value.
Q Who are the main importers of Gefitinib from India in Philippines?
The leading importers of Indian Gefitinib in Philippines include Natco LifeSciences Phillipines Inc , NATCO LIFESCIENCES PHILIPPINES, Ve Pharma Inc. , VE PHARMA INC, Ve Pharma Inc.. Natco LifeSciences Phillipines Inc is the largest buyer with 4 shipments worth $170.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Gefitinib.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 9 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 21 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
21 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists